2 March 2021 - The much-vaunted PHARMAC inquiry, being announced today, will investigate how the drug-buying agency can be brought into line with national health priorities.

Kelly McQuinlan has the rare hypermobile Ehlers-Danlos Syndrome. She calls it "an invisible illness"; she is often told her dislocations and other symptoms are all in her head. She is one of many New Zealanders with rare diseases, chronic disorders or cancer who have been pleading for better treatment, and often better drugs.

Read Newsroom article